BRIEF-European Commission approves Parsabiv for adults on hemodialysis

* European Commission approves Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism in adults on hemodialysis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.